I am glad that this makes sense. It is a complicated. Unfortunately, this is just the surface of the problem. There are more layers that are even more complicated and that I don’t understand. Let’s just say that there are complex interaction between genes, receptors and other proteins that need to be understood…
What we can do about it? First, we need to understand, how the signal is silenced. From what I understand, the idea is that the signal (gene expression) is silcenced by gene methylation. We would need to demethylate the areas affected. Demethylation agents exist, but we may need agents that target specific areas. Hopefully, the Baylor study will confirm that gene expression is indeed silenced/reduced, what the mechanism is (Methylation) and which areas are affected (given the differet symptom profiles here, this may vary from person to person). Then, we would need to find the right agents (if they exist).
But if AR overexpression is driving the problem, even if we successfully demethylate, the AR is still overexpressed which may resukt in remethylation of these areas. We may then have to look at ways to reduce AR expression. Or we may have to look for ways to increase gene expression in other ways without addressing the root cause. Unfortunately, I don’t know if and how this is possible. I haven’t researched deep enough.
There is a lot we still don’t know. That is why it is important to support all the ongoing research projects in the community here and new studies that may come up in the future.
Good night!